Watch Keeping the Science Ahead of Me: Aldo’s Story
We remember Aldo Del Col, who passed away in August 2019, due to unforeseen complications related to multiple myeloma. As a leading voice in the patient community, CTO worked with Aldo to understand the needs of patients and the public with respect to engaging with clinical trials. His visionary commitment to advancing healthcare through research and his tireless advocacy for patients and caregivers will continue to inspire our work.
Over the years, CTO has built relationships with health charities and patient organizations, such as Myeloma Canada, to help develop and distribute CTO resources within their communities and collaborate with CTO to move the needle on better patient and public engagement with clinical trials.
To learn more about CTO’s work with Myeloma Canada and other patient organizations click here.